PT Kalbe Farma Tbk. (PTKFF)

Market Cap	3.47B
Revenue (ttm)	2.06B
Net Income (ttm)	209.31M
Shares Out	n/a
EPS (ttm)	0.00
PE Ratio	16.58
Forward PE	15.23
Dividend	0.00 (2.75%)
Ex-Dividend Date	Jun 4, 2025

Volume	3,800
Average Volume	6,277
Open	0.0802
Previous Close	n/a
Day's Range	0.0802 - 0.0802
52-Week Range	0.0626 - 0.0958
Beta	-0.04
RSI	44.66
Earnings Date	Oct 30, 2025

About PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic divisions. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company pr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1966
• Employees: 12,903
• Stock Exchange: OTCMKTS
• Ticker Symbol: PTKFF

Financial Performance

In 2024, PT Kalbe Farma Tbk.'s revenue was 32.63 trillion, an increase of 7.16% compared to the previous year's 30.45 trillion. Earnings were 3.24 trillion, an increase of 17.13%.

Financial numbers in IDR